These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3727521)

  • 21. [Therapeutic effect of calf thymin on 35 cases of epidemic hemorrhagic fever].
    Xing GH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Oct; 4(5):297-300. PubMed ID: 6144394
    [No Abstract]   [Full Text] [Related]  

  • 22. [Immunomodulators in the combined treatment of atherosclerotic patients].
    Gandzha IM; Bobrik MV
    Vrach Delo; 1991 Apr; (4):67-9. PubMed ID: 2063573
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of splenin and dietetic nutrition on the indices of natural immunity in workers in the antibiotics industry].
    Poberezkina DIa; Kachalaĭ DP
    Vrach Delo; 1981 Aug; (8):112-4. PubMed ID: 7269496
    [No Abstract]   [Full Text] [Related]  

  • 24. [Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
    Auteri A; D'Aniello C; Falotico N; Saletti M; Di Perri T
    Recenti Prog Med; 1986 Sep; 77(9):423-8. PubMed ID: 3541085
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of splenin on the blood T-lymphocyte count in workers in the manufacture of amino acids and antibiotics].
    Gordienko VE
    Vrach Delo; 1984 Oct; (10):101-4. PubMed ID: 6240160
    [No Abstract]   [Full Text] [Related]  

  • 26. Thymopentin in experimental and clinical medicine.
    Surv Immunol Res; 1985; 4 Suppl 1():1-156. PubMed ID: 3898279
    [No Abstract]   [Full Text] [Related]  

  • 27. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S; Sulima D; Strzelecka G
    Proc Eur Dial Transplant Assoc; 1983; 19():800-3. PubMed ID: 6603617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum thymic activity in patients with cancer of the stomach and esophagus and its changes after the combined treatment including immunotherapy].
    Grinevich IuA; Kamenets LIa; Selezneva TN; Ganul VL; Okulov LV
    Klin Khir (1962); 1988; (5):19-22. PubMed ID: 3419029
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of splenin on liver function in alloxan diabetes in rats].
    Shevchenko AV; Doroshenko NM
    Fiziol Zh (1978); 1988; 34(4):104-8. PubMed ID: 3181501
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymopoietin pentapeptide treatment of sarcoidosis.
    Thivolet J; Faure M
    J Am Acad Dermatol; 1983 Nov; 9(5):773-4. PubMed ID: 6643779
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of thymopentin on the anaemia of chronic lymphoproliferative disorders.
    Paladini G; Tosato F
    Haematologica; 1986; 71(6):519-20. PubMed ID: 3104165
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of nerobol and splenin on liver function in experimental thyrotoxicosis].
    Doroshenko NM; Shevchenko AV
    Vrach Delo; 1981 Jan; (1):21-2. PubMed ID: 7210625
    [No Abstract]   [Full Text] [Related]  

  • 35. [Mechanism of action of splenin].
    Shevchenko AV; Doroshenko NM
    Fiziol Zh (1978); 1981; 27(2):176-9. PubMed ID: 7238920
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients.
    Przybilla B; Burg G; Schmoeckel C; Braun-Falco O
    Acta Derm Venereol; 1983; 63(6):524-9. PubMed ID: 6198843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymic hormone therapy for histiocytosis X?
    Davies EG; Levinsky RJ; Butler M; Broadbent V; Pritchard J; Chessells J
    N Engl J Med; 1983 Aug; 309(8):493-4. PubMed ID: 6348542
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunotherapy of head and neck cancer: an overview.
    Williamson A; Miller RH
    J La State Med Soc; 1988 Apr; 140(4):11-3. PubMed ID: 3259618
    [No Abstract]   [Full Text] [Related]  

  • 39. Thymopentin in chronic Trichophyton rubrum infection.
    Molin L; Bolla K
    Surv Immunol Res; 1985; 4 Suppl 1():135-8. PubMed ID: 3898286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Five-year experience with levamisole in cancer patients.
    Debois JM
    Ther Hung; 1981; 29(1):15-20. PubMed ID: 7188236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.